Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.

Imre NothVincent CottinNazia ChaudhuriTamera J CorteKerri A JohannsonMarlies WijsenbeekStéphane JouneauAndreas MichaelManuel QuaresmaKlaus B RohrAnne -Marie RussellSusanne StowasserToby M Mahernull null

Published in: The European respiratory journal (2021)

Home spirometry was a feasible and valid measure of lung function in patients with IPF and preserved FVC, but estimates of the rate of FVC decline obtained using home spirometry were poorly correlated with those based on clinic spirometry.

Keyphrases

lung function
idiopathic pulmonary fibrosis
cystic fibrosis
chronic obstructive pulmonary disease
air pollution
healthcare
interstitial lung disease
primary care
clinical trial
electronic health record
randomized controlled trial
deep learning
data analysis